Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05177458 · ClinicalTrials.gov registry record · NA

Exercise and Therapeutic Exposure

A NA study of PTSD, sponsored by Thomas Adams.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05177458: Completed NA study of PTSD, sponsored by Thomas Adams.

NCT05177458 is a NA study of PTSD that has completed, run by Thomas Adams. The registered enrollment target is 12 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05177458, a NA study of PTSD, has completed, sponsored by Thomas Adams.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The proposed project seeks to demonstrate that a brief bout of aerobic exercise can improve a particular type of therapeutic learning among victimins of interpersonal violence with or without posttraumatic stress disorder (PTSD).

Primary Outcome

Participant heart rate will be measured at baseline and after each imagery trial using a BIOPAC Bionomadix photo plethysmogram.

Conditions Studied

Interventions

  • BEHAVIORAL Active Control
  • BEHAVIORAL Experimental

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-04-14
Est. Completion 2023-07-18
Phase NA
Thomas Adams

2 total trials

What the finished NCT05177458 record still lists

NCT05177458 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (96% lower).

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Active Control is the first listed.

NCT05177458 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT05177458 about?

NCT05177458 is a clinical study titled "Exercise and Therapeutic Exposure". The proposed project seeks to demonstrate that a brief bout of aerobic exercise can improve a particular type of therapeutic learning among victimins of interpersonal violence with or without posttraumatic stress disorder (PTSD).

What is the current status of trial NCT05177458?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-04-14. Estimated completion is 2023-07-18.

What conditions does trial NCT05177458 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT05177458?

The interventions under investigation include: Active Control (BEHAVIORAL), Experimental (BEHAVIORAL).

Who is sponsoring clinical trial NCT05177458?

This trial is sponsored by Thomas Adams, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05177458 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05177458's enrollment target sits among peer trials

12 149th of 154 higher than 6 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05177458, the US trial registry maintained by the National Library of Medicine. NCT05177458 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.